News Greenberg Traurig’s Boston IP Group Congratulates 3 Clients on Winning 2022 BPLA ‘Invented Here!’ Awards Nov 11, 2022 Posted by Greenberg Traurig, LLP
News Greenberg Traurig Boston Receives 12 Metropolitan Rankings in U.S. News – Best Lawyers 2023 ‘Best Law Firms’ Report Nov 10, 2022 Posted by Greenberg Traurig, LLP
News Azzur Group Welcomes Cybersecurity Expert, Mariano Mattei, to Lead Cybersecurity Services for Life Science Clients Nov 08, 2022
News Greenberg Traurig’s Andrew Tibbetts and Andrew Tsui Presented at MassBio 2022 Digital Health Impact Conference Nov 08, 2022 Posted by Greenberg Traurig, LLP
News Sumitomo Pharma Oncology to Present Preliminary Clinical Data Evaluating Investigational Agent TP-3654 at the 64th ASH Annual Meeting & Exposition Nov 03, 2022 Posted by Sumitomo Pharma Oncology, Inc.
News Sumitomo Pharma Oncology Receives Orphan Drug Designation for DSP-5336, an Investigational Menin and Mixed-Lineage Leukemia Binding Protein for Treatment of Acute Myeloid Leukemia Nov 03, 2022 Posted by Sumitomo Pharma Oncology, Inc.
News EdiGene to Present Preliminary Safety and Efficacy Results of an Investigator Initiated Trial for ET-01, its Investigational Gene Editing Hematopoietic Stem Cell Therapy, at the 64th American Society Nov 03, 2022
News Data-driven Generation of Perturbation Networks for Relative Binding Free Energy Calculations Nov 02, 2022
News Greenberg Traurig’s Jeffrey W. Greene Named a ‘Massachusetts Go To Lawyer: Cybersecurity and Data Privacy 2022’ Nov 02, 2022 Posted by Greenberg Traurig, LLP
%20(3).png)
